Skip to main content
SpringerLink
Log in

Prevalence and mechanisms of linezolid resistance among staphylococcal clinical isolates from Egypt

  • Original Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The emergence of methicillin-resistant staphylococci necessitated the search for alternative agents as linezolid, introduced to treat infections due to multidrug-resistant bacteria. Linezolid resistance has since emerged, yet its global prevalence remains low. In Egypt, little is known about the situation. We investigated the prevalence and mechanisms of resistance among Egyptian staphylococcal clinical isolates. Linezolid resistance among 232 staphylococcal isolates obtained from Alexandria Main Hospitals between 2011 and 2016 was assessed using disc diffusion and minimum inhibitory concentration. Resistant isolates were checked for cfr presence using polymerase chain reaction. The V domain of different alleles of 23S rRNA gene was investigated for mutations. Selection for linezolid-resistant mutants was performed in vitro through serial passages in linezolid sub-inhibitory concentrations. Combinations of linezolid with imipenem or anti-inflammatory agents were investigated using time-kill and modified checkerboard assays. Three Staphylococcus haemolyticus isolates (1.3%) from 2015 to 2016 were linezolid-resistant. One isolate carried cfr which was plasmid-borne, and together with another isolate which had a G2603T point mutation in the V domain of 23S rRNA gene. Successive exposure to linezolid sub-inhibitory concentrations was selected for three resistant Staphylococcus aureus mutants out of ten susceptible isolates. These mutants were more resistant towards different antibiotic classes than their susceptible parents. Linezolid combinations with imipenem, ibuprofen, or aspirin were synergistic against the isolates and mutants. Despite unregulated use of linezolid, resistance remains fairly low among the Egyptian isolates. Strict antimicrobial stewardship guidelines are needed in hospitals and the community to guard against further evolution of resistant mutants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

All raw data are available from the corresponding author upon reasonable request.

References

  1. Davies J, Davies D (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74(3):417–433

    Article  CAS  Google Scholar 

  2. Moghnieh RA, Kanafani ZA, Tabaja HZ, Sharara SL, Awad LS, Kanj SS (2018) Epidemiology of common resistant bacterial pathogens in the countries of the Arab League. Lancet Infect Dis 18(12):e379–e394. https://doi.org/10.1016/S1473-3099(18)30414-6

    Article  PubMed  Google Scholar 

  3. Ager S, Gould K (2012) Clinical update on linezolid in the treatment of Gram-positive bacterial infections. Infect Drug Resist 5:87–102

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Moellering RC (2003) Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 138(2):135–142

    Article  CAS  Google Scholar 

  5. Cidral TA, Carvalho MC, Figueiredo AM, de Melo MC (2015) Emergence of methicillin-resistant coagulase-negative staphylococci resistant to linezolid with rRNA gene C2190T and G2603T mutations. Apmis 123(10):867–871. https://doi.org/10.1111/apm.12426

    Article  CAS  PubMed  Google Scholar 

  6. Meka VG, Gold HS (2004) Antimicrobial resistance to linezolid. Clin Infect Dis 39(7):1010–1015

    Article  CAS  Google Scholar 

  7. Long KS, Vester B (2012) Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob Agents Chemother 56(2):603–612

    Article  CAS  Google Scholar 

  8. Musumeci R, Calaresu E, Gerosa J, Oggioni D, Bramati S, Morelli P, Mura I, Piana A, Are BM, Cocuzza CE (2016) Resistance to linezolid in Staphylococcus spp. clinical isolates associated with ribosomal binding site modifications: novel mutation in domain V of 23S rRNA. New Microbiol 39(4):269–273

    CAS  PubMed  Google Scholar 

  9. Stefani S, Bongiorno D, Mongelli G, Campanile F (2010) Linezolid resistance in staphylococci. Pharmaceuticals (Basel, Switzerland) 3(7):1988–2006

    Article  CAS  Google Scholar 

  10. Locke JB, Hilgers M, Shaw KJ (2009) Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother 53(12):5265–5274

    Article  CAS  Google Scholar 

  11. Toh SM, Xiong L, Arias CA, Villegas MV, Lolans K, Quinn J, Mankin AS (2007) Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol Microbiol 64(6):1506–1514

    Article  CAS  Google Scholar 

  12. Hutchinson DK (2003) Oxazolidinone antibacterial agents: a critical review. Curr Top Med Chem 3(9):1021–1042

    Article  CAS  Google Scholar 

  13. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, Moellering RC, Ferraro MJ (2001) Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet (London, England) 358(9277):207–208. https://doi.org/10.1016/s0140-6736(01)05410-1

    Article  CAS  Google Scholar 

  14. Flamm RK, Mendes RE, Hogan PA, Streit JM, Ross JE, Jones RN (2016) Linezolid surveillance results for the United States (LEADER Surveillance Program 2014). Antimicrob Agents Chemother 60(4):2273–2280

    Article  CAS  Google Scholar 

  15. Mendes RE, Deshpande L, Streit JM, Sader HS, Castanheira M, Hogan PA, Flamm RK (2018) ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries. J Antimicrob Chemother 73(7):1880–1887

    Article  CAS  Google Scholar 

  16. Abouelfetouh A (2017) The status of methicillin resistance among Egyptian Staphylococcus aureus isolates: an overview. Infect Disord Drug Targets 17(1):67–69

    Article  CAS  Google Scholar 

  17. Azzab MM, El-Sokkary RH, Tawfeek MM, Gebriel MG (2017) Multidrug-resistant bacteria among patients with ventilatorassociated pneumonia in an emergency intensive care unit, Egypt. East Mediterr Health J 22(12):894–903

    Article  Google Scholar 

  18. Hashem AA, Abd El Fadeal NM, Shehata AS (2017) In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital. J Med Microbiol 66(6):744–752. https://doi.org/10.1099/jmm.0.000490

    Article  CAS  PubMed  Google Scholar 

  19. Ashour HM, el-Sharif A (2007) Microbial spectrum and antibiotic susceptibility profile of gram-positive aerobic bacteria isolated from cancer patients. J Clin Oncol 25(36):5763–5769

    Article  Google Scholar 

  20. ElSayed N, Ashour M, Amine AEK (2018) Vancomycin resistance among Staphylococcus aureus isolates in a rural setting, Egypt. Germs 8(3):134–139. https://doi.org/10.18683/germs.2018.1140

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. CLSI (2020) Clinical and Laboratory Standards Institute. 2020. Performance standards for antimicrobial susceptibility testing: 30th informational supplement M100-ED30. Wayne, PA

  22. Kateete DP, Kimani CN, Katabazi FA, Okeng A, Okee MS, Nanteza A, Joloba ML, Najjuka FC (2010) Identification of Staphylococcus aureus: DNase and mannitol salt agar improve the efficiency of the tube coagulase test. Ann Clin Microbiol Antimicrob 9:23

    Article  Google Scholar 

  23. Boerlin P, Kuhnert P, Hussy D, Schaellibaum M (2003) Methods for identification of Staphylococcus aureus isolates in cases of bovine mastitis. J Clin Microbiol 41(2):767–771

    Article  CAS  Google Scholar 

  24. Ince D, Zhang X, Hooper DC (2003) Activity of and resistance to moxifloxacin in Staphylococcus aureus. Antimicrob Agents Chemother 47(4):1410–1415

    Article  CAS  Google Scholar 

  25. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor

  26. Kehrenberg C, Schwarz S (2006) Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Chemother 50(4):1156–1163. https://doi.org/10.1128/aac.50.4.1156-1163.2006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Letchumanan V, Chan KG, Lee LH (2015) An insight of traditional plasmid curing in Vibrio species. Front Microbiol 6:735

    PubMed  PubMed Central  Google Scholar 

  28. Pillai SK, Sakoulas G, Wennersten C, Eliopoulos GM, Moellering RC Jr, Ferraro MJ, Gold HS (2002) Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis 186(11):1603–1607. https://doi.org/10.1086/345368

    Article  CAS  PubMed  Google Scholar 

  29. Singh SR, Bacon AE 3rd, Young DC, Couch KA (2009) In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53(10):4495–4497

    Article  CAS  Google Scholar 

  30. Orhan G, Bayram A, Zer Y, Balci I (2005) Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol 43(1):140–143

    Article  CAS  Google Scholar 

  31. Biedenbach DJ, Moet GJ, Jones RN (2004) Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 50(1):59–69

    Article  CAS  Google Scholar 

  32. Layer F, Vourli S, Karavasilis V, Strommenger B, Dafopoulou K, Tsakris A, Werner G, Pournaras S (2018) Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals. J Antimicrob Chemother 73(5):1181–1184

    Article  CAS  Google Scholar 

  33. Morales G, Picazo JJ, Baos E, Candel FJ, Arribi A, Pelaez B, Andrade R, de la Torre MA, Fereres J, Sanchez-Garcia M (2010) Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis 50(6):821–825

    Article  CAS  Google Scholar 

  34. LaMarre J, Mendes RE, Szal T, Schwarz S, Jones RN, Mankin AS (2013) The genetic environment of the cfr gene and the presence of other mechanisms account for the very high linezolid resistance of Staphylococcus epidermidis isolate 426-3147L. Antimicrob Agents Chemother 57(3):1173–1179

    Article  CAS  Google Scholar 

  35. Chamon RC, Iorio NL, Cavalcante FS, Teodoro CR, de Oliveira AP, Maia F, dos Santos KR (2014) Linezolid-resistant Staphylococcus haemolyticus and Staphylococcus hominis: single and double mutations at the domain V of 23S rRNA among isolates from a Rio de Janeiro hospital. Diagn Microbiol Infect Dis 80(4):307–310

  36. Arias CA, Vallejo M, Reyes J, Panesso D, Moreno J, Castaneda E, Villegas MV, Murray BE, Quinn JP (2008) Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase. J Clin Microbiol 46(3):892–896

    Article  CAS  Google Scholar 

  37. Zhou W, Niu D, Cao X, Ning M, Zhang Z, Shen H, Zhang K (2015) Clonal dissemination of linezolid-resistant Staphylococcus capitis with G2603T mutation in domain V of the 23S rRNA and the cfr gene at a tertiary care hospital in China. BMC Infect Dis 15:97

    Article  Google Scholar 

  38. Rio-Marques L, Hartke A, Bizzini A (2014) The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Microb Drug Resist (Larchmont NY) 20(6):539–543

    Article  CAS  Google Scholar 

  39. Sweeney MT, Zurenko GE (2003) In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms. Antimicrob Agents Chemother 47(6):1902–1906

    Article  CAS  Google Scholar 

  40. Yehia H, El Said M, Azmy M, Badawy M, Mansy S, Gohar H, Madany N (2016) Effect of linezolid alone and in combination with other antibiotics, on methicillin-resistant Staphylococcus aureus. J Egypt Soc Parasitol 46(1):57–66

    Article  Google Scholar 

  41. Godon N, Denizot S, Podevin G, Caillon J, Potel G, Christophe Roze J, Gras-Le Guen C (2006) Effectiveness of linezolid and imipenem association in the treatment of severe community-acquired pneumonia in children: two case reports. Scand J Infect Dis 38(5):381–383

    Article  Google Scholar 

  42. Zimmermann P, Curtis N (2017) Antimicrobial effects of antipyretics. Antimicrob Agents Chemother 61(4):e02268-16. https://doi.org/10.1128/AAC.02268-16

Download references

Acknowledgements

The authors would like to thank Dr. Marwa Naguib, Dr. Eva Adel, and Dr. Mustafa Alseqely for their help in isolate collection and PD Dr. med. Wilma Ziebuhr, Prof. Andrew Whitelaw Dr. Revathi Gunturu for their helpful insights.

Funding

This work was supported by the Academic Thesis Research Fund (ATRF), Faculty of Pharmacy, Alexandria University and DFG grant ZI665/3-1.

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, 1 Khartoum Sq., Azarita, Alexandria, 21521, Egypt

    Lina Maarouf, Hoda Omar, Moustafa El-Nakeeb & Alaa Abouelfetouh

Authors
  1. Lina Maarouf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hoda Omar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Moustafa El-Nakeeb
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alaa Abouelfetouh
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Lina Maarouf carried out the experimental part of the study, including data analysis, and participated in manuscript writing. Hoda Omar followed up the performance of the experiments, analysis of the data, and manuscript writing. Moustafa El-Nakeeb designed the study and followed the progress of the work and writing of the manuscript. Alaa Abouelfetouh designed the study, participated in data analysis, and manuscript writing. All authors approved of the final manuscript.

Corresponding author

Correspondence to Alaa Abouelfetouh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethics statement

No human subjects or animals were involved so approval was not required.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maarouf, L., Omar, H., El-Nakeeb, M. et al. Prevalence and mechanisms of linezolid resistance among staphylococcal clinical isolates from Egypt. Eur J Clin Microbiol Infect Dis 40, 815–823 (2021). https://doi.org/10.1007/s10096-020-04045-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-020-04045-w

Keywords

Search

Navigation